留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

胰岛移植临床技术操作规范(2019版)

中华医学会器官移植学分会

中华医学会器官移植学分会. 胰岛移植临床技术操作规范(2019版)[J]. 器官移植, 2019, 10(6): 621-627. doi: 10.3969/j.issn.1674-7445.2019.06.001
引用本文: 中华医学会器官移植学分会. 胰岛移植临床技术操作规范(2019版)[J]. 器官移植, 2019, 10(6): 621-627. doi: 10.3969/j.issn.1674-7445.2019.06.001
Branch of Organ Transplantation of Chinese Medical Association. Clinical technical operation specification of pancreatic islet transplantation (2019 edition)[J]. ORGAN TRANSPLANTATION, 2019, 10(6): 621-627. doi: 10.3969/j.issn.1674-7445.2019.06.001
Citation: Branch of Organ Transplantation of Chinese Medical Association. Clinical technical operation specification of pancreatic islet transplantation (2019 edition)[J]. ORGAN TRANSPLANTATION, 2019, 10(6): 621-627. doi: 10.3969/j.issn.1674-7445.2019.06.001

胰岛移植临床技术操作规范(2019版)

doi: 10.3969/j.issn.1674-7445.2019.06.001
基金项目: 

国家自然科学基金 81570680

国家自然科学基金 81571555

详细信息
    通讯作者:

    王树森,1976年生,博士,教授,研究方向为胰岛移植,Email:shusen@vip.163.com;程颖,1975年生,博士,教授,研究方向为胰岛移植,Email:chengying75@sina.com

  • 中图分类号: R617, R619

Clinical technical operation specification of pancreatic islet transplantation (2019 edition)

  • 摘要: 为了进一步规范胰岛移植的临床技术操作,中华医学会器官移植学分会组织器官移植学专家从胰岛移植的适应证和禁忌证、供者胰岛制备及移植前处理、胰岛移植受者的术前检查和准备、胰岛移植植入术的技术操作规范、胰岛移植的术后处理、胰岛移植的免疫抑制方案、胰岛移植的并发症、胰岛移植的术后随访、自体胰岛移植等方面,制订本规范。
  • [1] SHAPIRO AM, LAKEY JR, RYAN EA, et al. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen[J]. N Engl J Med, 2000, 343(4):230-238. doi: 10.1056/NEJM200007273430401
    [2] BELLIN MD, BARTON FB, HEITMAN A, et al. Potent induction immunotherapy promotes long-term insulin independence after islet transplantation in type 1 diabetes[J]. Am J Transplant, 2012, 12(6):1576-1583. DOI: 10.1111/j.1600-6143.2011.03977.x.
    [3] BERNEY T, FERRARI-LACRAZ S, BÜHLER L, et al. Long-term insulin-independence after allogeneic islet transplantation for type 1 diabetes: over the 10-year mark[J]. Am J Transplant, 2009, 9(2):419-423. DOI: 10.1111/j.1600-6143.2008.02481.x.
    [4] HERING BJ, CLARKE WR, BRIDGES ND, et al. Phase 3 trial of transplantation of human islets in type 1 diabetes complicated by severe hypoglycemia[J]. Diabetes Care, 2016, 39(7):1230-1240. DOI: 10.2337/dc15-1988.
    [5] GALINDO RJ, WALLIA A. Hyperglycemia and diabetes mellitus following organ transplantation[J]. Curr Diab Rep, 2016, 16(2):14. DOI: 10.1007/s11892-015-0707-1.
    [6] JENSSEN T, HARTMANN A. Emerging treatments for post-transplantation diabetes mellitus[J]. Nat Rev Nephrol, 2015, 11(8):465-477. DOI: 10.1038/nrneph.2015.59.
    [7] 王树森, 陈实.移植学[M].北京:人民卫生出版社, 2012.
    [8] KADDIS JS, DANOBEITIA JS, NILAND JC, et al. Multicenter analysis of novel and established variables associated with successful human islet isolation outcomes[J]. Am J Transplant, 2010, 10(3):646-656. DOI: 10.1111/j.1600-6143.2009.02962.x.
    [9] HANLEY SC, PARASKEVAS S, ROSENBERG L. Donor and isolation variables predicting human islet isolation success[J]. Transplantation, 2008, 85(7):950-955. DOI: 10.1097/TP.0b013e3181683df5.
    [10] NANO R, CLISSI B, MELZI R, et al. Islet isolation for allotransplantation: variables associated with successful islet yield and graft function[J]. Diabetologia, 2005, 48(5):906-912. doi: 10.1007/s00125-005-1725-3
    [11] O' GORMAN D, KIN T, MURDOCH T, et al. The standardization of pancreatic donors for islet isolation[J]. Transplant Proc, 2005, 37(2):1309-1310. doi: 10.1097/01.tp.0000172216.47547.d5
    [12] NG MC, LEE SC, KO GT, et al. Familial early-onset type 2 diabetes in Chinese patients: obesity and genetics have more significant roles than autoimmunity[J]. Diabetes Care, 2001, 24(4):663-671. doi: 10.2337/diacare.24.4.663
    [13] KIN T, SHAPIRO AM. Surgical aspects of human islet isolation[J]. Islets, 2010, 2(5):265-273. doi: 10.4161/isl.2.5.13019
    [14] SCHUETZ C, MARKMANN JF. Islet cell transplant: update on current clinical trials[J]. Curr Transplant Rep, 2016, 3(3):254-263. DOI: 10.1007/s40472-016-0103-z.
    [15] OWEN RJ, RYAN EA, O' KELLY K, et al. Percutaneous transhepatic pancreatic islet cell transplantation in type 1 diabetes mellitus: radiologic aspects[J]. Radiology, 2003, 229(1):165-170. doi: 10.1148/radiol.2291021632
    [16] 赵玉沛.曾宪九胰腺病学[M].北京:人民卫生出版社, 2018.
    [17] VILLIGER P, RYAN EA, OWEN R, et al. Prevention of bleeding after islet transplantation: lessons learned from a multivariate analysis of 132 cases at a single institution[J]. Am J Transplant, 2005, 5(12):2992-2998. doi: 10.1111/j.1600-6143.2005.01108.x
    [18] VENTURINI M, ANGELI E, MAFFI P, et al. Technique, complications, and therapeutic efficacy of percutaneous transplantation of human pancreatic islet cells in type 1 diabetes: the role of US[J]. Radiology, 2005, 234(2):617-624. doi: 10.1148/radiol.2342031356
    [19] KAWAHARA T, KIN T, KASHKOUSH S, et al. Portal vein thrombosis is a potentially preventable complication in clinical islet transplantation[J]. Am J Transplant, 2011, 11(12):2700-2707. DOI: 10.1111/j.1600-6143.2011.03717.x.
    [20] RYAN EA, PATY BW, SENIOR PA, et al. Risks and side effects of islet transplantation[J]. Curr Diab Rep, 2004, 4(4):304-309. doi: 10.1007/s11892-004-0083-8
    [21] RAFAEL E, RYAN EA, PATY BW, et al. Changes in liver enzymes after clinical islet transplantation[J]. Transplantation, 2003, 76(9):1280-1284. doi: 10.1097/01.TP.0000098822.85924.4C
    [22] MAFFI P, ANGELI E, BERTUZZI F, et al. Minimal focal steatosis of liver after islet transplantation in humans: a long-term study[J]. Cell Transplant, 2005, 14(10):727-733. doi: 10.3727/000000005783982567
    [23] TOSO C, ISSE K, DEMETRIS AJ, et al. Histologic graft assessment after clinical islet transplantation[J]. Transplantation, 2009, 88(11): 1286-1293. DOI: 10.1097/TP.0b013e3181bc06b0.
    [24] GALA-LOPEZ B, KIN T, O' GORMAN D, et al. Microbial contamination of clinical islet transplant preparations is associated with very low risk of infection[J]. Diabetes Technol Ther, 2013, 15(4):323-327. DOI: 10.1089/dia.2012.0297.
    [25] RICKELS MR, KEARNS J, MARKMANN E, et al. HLA sensitization in islet transplantation[J]. Clin Transpl, 2006, 413-420. https://www.researchgate.net/publication/5487854_HLA_Sensitization_in_Islet_Transplantation
    [26] BELLIN MD, FREEMAN ML, GELRUD A, et al. Total pancreatectomy and islet autotransplantation in chronic pancreatitis: recommendations from pancreasfest[J]. Pancreatology, 2014, 14(1):27-35. DOI: 10.1016/j.pan.2013.10.009.
    [27] DESAI CS, VONDERAU JS, MA X, et al. The first report of total pancreatectomy and islet cell autotransplantation for pancreatic cystosis in patient with cystic fibrosis[J]. Pancreas, 2019, 48(6):e54-e55. DOI: 10.1097/MPA.0000000000001323.
    [28] MCEACHRON KR, SKUBE ME, YANG Y, et al. Utility of arginine stimulation testing in preoperative assessment of children undergoing total pancreatectomy with islet autotransplantation[J]. Clin Transplant, 2019: e13647. DOI: 10.1111/ctr.13647.
    [29] KIZILGUL M, WILHELM JJ, DUNN TB, et al. The prognostic significance of glutamic acid decarboxylase antibodies in patients with chronic pancreatitis undergoing total pancreatectomy with islet autotransplantation[J]. Diabetes Metab, 2019, 45(3):301-305. DOI: 10.1016/j.diabet.2018.01.001.
    [30] BEAMISH CA, GABER AO, AFSHAR SF, et al. Variability in endocrine cell identity in patients with chronic pancreatitis undergoing islet autotransplantation[J]. Am J Transplant, 2019, 19(5):1568-1576. DOI: 10.1111/ajt.15154.
    [31] ALI KF, SAN MARTIN VT, WALSH RM, et al. Change in functional beta cell capacity with time following autologous islet transplantation[J]. Pancreas, 2019, 48(5):656-661. DOI: 10.1097/MPA.0000000000001315.
  • 加载中
计量
  • 文章访问数:  37
  • HTML全文浏览量:  5
  • PDF下载量:  7
  • 被引次数: 0
出版历程
  • 收稿日期:  2019-08-08
  • 网络出版日期:  2021-01-19
  • 刊出日期:  2019-11-15

目录

    /

    返回文章
    返回